Independent register of U.S. FDA drug recalls · updated Oct 12, 2026
RxRecalls Get alerts

Class II drug recalls - moderate risk

Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.

14,535 recalls, newest first.

Class II · Moderate risk

Trimix (A;ph,pa)

Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Terminated Sterility / contamination Montana Compounding Pharmacy D-1125-2015
Class II · Moderate risk

Trimix (A;ph,pa)

Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Terminated Sterility / contamination Montana Compounding Pharmacy D-1124-2015
Class II · Moderate risk

Hyaluronidase

Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Terminated Sterility / contamination Montana Compounding Pharmacy D-1123-2015
Class II · Moderate risk

Bimix (Phent;pap)

Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Terminated Sterility / contamination Montana Compounding Pharmacy D-1120-2015
Class II · Moderate risk

Avastin

Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Terminated Sterility / contamination Montana Compounding Pharmacy D-1119-2015
Class II · Moderate risk

Alprostadil

Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Terminated Sterility / contamination Montana Compounding Pharmacy D-1118-2015
Class II · Moderate risk

Alprostadil

Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Terminated Sterility / contamination Montana Compounding Pharmacy D-1117-2015
Class II · Moderate risk

Famotidine Tablets

CGMP Deviations: Failure of the manufacturer, Wockhardt Ltd, to adequately investigate customer complaints.

Terminated cGMP deviation Allegiant Health D-1134-2015
Class II · Moderate risk

Azithromycin 500 mg tablets

cGMP Deviations: This recall is a result of the original manufacturer's recall, in which the firm did not adequately investigate customer complaints.

Terminated cGMP deviation PD-Rx Pharmaceuticals, Inc. D-0561-2016
Class II · Moderate risk

Azithromycin Tablets

cGMP Deviations: This recall is a result of the original manufacturer's recall, in which the firm did not adequately investigate customer complaints.

Terminated cGMP deviation PD-Rx Pharmaceuticals, Inc. D-0560-2016
Class II · Moderate risk

Kabiven

Labeling: Label Error on Declared Strength: Labeled 3.1% Amino Acids but contains 3.3% Amino Acids

Terminated Labeling / mix-up Fresenius Kabi USA, LLC D-1114-2015
Class II · Moderate risk

Alinia (nitazoxanide)

Failed Stability Specifications: Product failed to meet 12 months long term stability specification for viscosity

Terminated Stability / shelf life Romark Laboratories, L.C. D-0983-2015
Class II · Moderate risk

Bi-Est (estriol,estradiol)

Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.

Terminated Cross-contamination South Coast Specialty Compounding, Inc. D-1415-2015
Class II · Moderate risk

Bi-Est (estriol,estradiol)

Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.

Terminated Cross-contamination South Coast Specialty Compounding, Inc. D-1414-2015
Class II · Moderate risk

Estradiol cream

Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.

Terminated Cross-contamination South Coast Specialty Compounding, Inc. D-1413-2015
Class II · Moderate risk

Bi-Est (estriol,estradiol)

Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.

Terminated Cross-contamination South Coast Specialty Compounding, Inc. D-1412-2015

Recalls by year